All posts tagged
In Geneva, the Capital of Peace, 10 Biotechs are putting up a Fight
How Biotech is Mastering Multiple Sclerosis: A Review
Swiss Antibodies and the US NIH will fight Ancient Viral DNA causing ALS
Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment
First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis!
This Swiss Biotech is Using an Ancient Virus in our Genome to Fight Multiple Sclerosis
Will there be a New Merck-Serono?
Labiotech UG, All Rights Reserved -
Send this to friend